Researchers have developed an injectable inflammation-responsive hydrogel (IRH), which tests in mice showed can deliver an anti-inflammatory drug directly to the retina of the eye. Reporting on in ...

Bispecific antibody fares well against faricimab, two gene therapies extend treatment inte ...

A new study links spring daylight saving time changes to an up to 30% increased risk of retinal vascular disease.

Dentists are exposed to intense lighting for long hours, but its long-term impact on eye health is often overlooked. This study evaluates whether chronic exposure to dental lighting, especially blue ...

A research team has successfully incorporated anti-inflammatory drugs into a hydrogel to suppress inflammation in the retina and effectively deliver the drugs to the inflamed area. Age-related macular ...

A real-world safety study found that patients treated with brolucizumab had low occurrences of intraocular inflammation, retinal vascular occlusion, and retinal vasculitis. A study published in ...

A new research paper was published in Aging (Aging-US) on January 31, 2025, in Volume 17, Issue 2, titled "Cysteinyl leukotriene receptor 1 modulates retinal immune cells, vascularity and proteolytic ...

In July, we reported on cases of unexplained ocular inflammation associated with pegcetacoplan (Syfovre), a treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD).

Cynthia Toth, MD, of Duke University, discusses new BabySTEPS research showing that retinal nerve fiber layer and choroidal thickness on OCT correlate with 2-year neurodevelopmental outcomes in ...